Search News Archives
Follow us on
Conferences | Events

Media Partners


Attana's Technology Applied to Develop more Efficent Processes in Drug Development

publication date: Jan 3, 2019
author/source: Attana

Serotec Figure 3The R&D team at Bio-Rad AbD Serotec in Munich has developed a new type of specific antibodies.

These new andbodies can be used as a tool both pre-clincally and clinically to develop new therapeutic antibodies. Attana's technology was applied to select and optimize the best of these new antibodies.

The paper describes the different types of these antibody tools, so called anti-idiotypic antibodies. An anti-idiotypic antibody interacts with a therapeutic antibody. An anti-idiotypic antibody of type 1 can only interact with unbound therapeutic antibodies and can thus be used for detecting unbound antibodies in serum. Type 2 can detect both unbound and target-bound therapeutic antibodies therefore determining the total concentration of therapeutic antibodies in the body. In the paper the authors descibe the develepment of a new type of anti-idiotic antibodies, type 3. The type 3 antibody interacts only with receptor-bound therapeutic antibodies, hence it can be used to validate that the therapeutic antibodies interact at the right place in the body. Attana's technology has been applied to develop the desired interaction profile of these typ 3 antibodies to secure a high specificity and interaction properties.

The Board of directors for Attana consider that the information in this press release is not likely to have a significant effect on the share prices, but is of general interest for the shareholders and hence should be communicated.

Attana was founded in 2002 with the vision of in-vitro characterization of molecular interactions mimicking in-vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays. Attana’s products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences.


View | download paper


Popular this Month


Chromatography in Cannabis Testing


New Catalogue of Infectious Disease Antibodies and Antigens


Acquisition of B&W Tek takes Metrohm’s Spectroscopy Portfolio to the Next Level


Gilson announce the release of the extended mass range VERITY® 1910 MS Detector


NanoFCM Opens European Office and Centre of Excellence for Scientific Application Support


Hitachi High-Technologies Launches Two New Scanning Electron Microscopes


Discovery Park & MedCity to Partner on Prestigious Angels In MedCity Programme


Merck Lectureship 2019 Awarded to Susumu Kitagawa


BioCity Invests in Carbon Recycling Start-Up, Deep Branch Biotechnology


Agilent Announces Unique Portfolio to Advance Immunotherapy






Can't find what you are looking for?

Search by company or by product

Company Name:




Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd